Welcome

NanGenex, member of the DRGT Group, is a Druggability Enabling High Throughput NanoActiveâ„¢ Technology Platform Company. The company utilizes its integrated platform to provide breakthrough solutions to pharmaceutical and biotech companies in order to develop new generations of NanoActive products with significant performance benefits over conventional approaches.

The technology platform enables NanGenex to generate proprietary NanoActiveâ„¢ materials by altering their physico-chemical properties to substantially improve their solubility, dissolution rate and bioavailability.


News

Latest Press Release

SAN FRANCISCO, CA, January 12, 2012
Druggability Technologies Announces Financial Investment by SPCH

Druggability Technologies Holdings Limited (DRGT), a privately held biotechnology platform company, announced today that it has completed an initial round of financing totaling $4,000,000.

Read more

 

 

Latest events

30 April - 1 May 2012, San Diego, USA                                                                                 Drug Delivery and Formulation America 2012 

19-22 March, 2012, Istanbul, Turkey                                                                                      8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

1-2 March, 2012, Krems, Austria                                                                                            BioNanoMed 2012

 

 

Upcoming events 

18-21 June 2012, Boston, USA                                                                                              Bio International Convention 2012

15-17 July 2012, Amsterdam, Netherlands                                                                              Colloids and Nanomedicine 2012

17 - 19 September 2012,  Budapest, Hungary                                                                          6th European Pharma Licensing Symposium Budapest

9-11 October 2012, Madrid, Spain                                                                                          CPHI 2012